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Porcine reproductive and respiratory syndrome virus (PRRSV)-induced reproductive problems are characterized by
embryonic death, late-term abortions, early farrowing and increase in number of dead and mummified fetuses, and
weak-born piglets. The virus recovery from fetal tissues illustrates transplacental infection, but despite many studies
on the subject, the means by which PRRSV spreads from mother to fetus and the exact pathophysiological basis of
the virus-induced reproductive failure remain unexplained. Recent findings from our group indicate that the
endometrium and placenta are involved in the PRRSV passage from mother to fetus and that virus replication in
the endometrial/placental tissues can be the actual reason for fetal death. The main purpose of this review is to
clarify the role that PRRSV replication and PRRSV-induced changes in the endometrium/placenta play in the
pathogenesis of PRRSV-induced reproductive failure in pregnant sows. In addition, strategies to control placental
and transplacental PRRSV infection are discussed.Table of contents
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Figure 1 Porcine placental barrier and conceptus. Representations
of the placental barrier in swine (A) and conceptus within the uterine
horn (B).
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placenta
In order to get a full understanding of PRRSV-induced
reproductive failure, we will first review morphology and
function of the porcine placenta.
Gestation begins with fertilization of an ovulated oo-
cyte by sperm. After fertilization, the zygote undergoes
time-dependent mitotic divisions, resulting in different
cleavage stage embryos. Pig embryos reach the uterus on
days 2–3 and migrate as blastocysts through both uter-
ine horns between days 6 and 12 after ovulation [1]. In
the uterus, blastocysts attach to the uterine epithelial
cells at 13–14 days after fertilization [2]. Implantation
involves phases of trophoblast-uterine epithelial cell
apposition, adhesion, and microvillus attachment [3].
The initial implantation is accomplished primarily by
the omphalochorion (yolk sac covered by trophoblast),
which is then the dominant membrane, albeit only for a
short time. On day 14, the allantois develops, and pla-
cental development starts 17 days after fertilization. By
day 24–30 of gestation, the allantois attaches all around
the periphery, the yolk sac shrinks and the placenta is
completely established [4].
Mossman defines the placenta as an intimate appos-
ition or fusion of fetal organs to maternal tissues for
physiological interchange [4]. The placenta is an essen-
tial organ in permitting viviparity, a reproductive strat-
egy acquired by eutherian mammals, in which fetal
development proceeds within the female reproductive
tract. Thus, placentation is fundamental in creating the
environment in which the embryo and fetus develop.
The quality of the embryonic and fetal environment has
long lasting effects, influencing postnatal health and dis-
ease [5].
Based on histology, the placentae of eutherians are
currently grouped in epitheliochorial, synepitheliocho-
rial, endotheliochorial and haemochorial placentae. Pigs
have an incomplete diffuse epitheliochorial placenta with
atrophy at the peripheral tips. The swine placenta is a
typical diffuse epitheliochorial organ without invasion
[4]. Neither invasion of fetal tissue into the maternal
endometrium, nor endometrial decidualization occurs.
Instead, maternal and fetal microvilli appose and inter-
digitate giving a clear distinction between maternal and
fetal tissues (semiplacenta). Therefore, in the present
paper the terms “endometrium” and “placenta” are used
to designate the maternal and fetal counterparts, re-
spectively. Maternal and fetal blood is separated by six
tissue layers (Figure 1A), which form a firm barrier. Even
maternal antibodies are prevented to pass to fetuses dur-
ing gestation [6]. Since no invasion occurs, much of the
placenta/embryonic development depends on the uterine
milk or embryotroph (endometrial gland secretions).
Nevertheless, it is interesting to know that although theungulate placenta is epitheliochorial, the placental bar-
rier in certain regions is thinner than that found in car-
nivores with the endotheliochorial placenta (in this type
of placenta, the endometrial epithelium under the pla-
centa does not survive implantation, and fetal chorionic
epithelial cells come in contact with maternal endothe-
lial cells) [7].
The porcine placenta is diffuse, and almost the entire
surface of the allantochorion (embryonic membrane
consisting of a fused allantois and chorion) is involved in
the formation of placenta (Figure 1B). The porcine chor-
ion is formed by an extraembryonic mesoderm and
trophoblast. Porcine fetuses have individual fetal mem-
branes and starting from 39–55 days of gestation large
placental zones of the individual concepti are terminated
by the two extremities of the fetal sacs that include
paraplacental and ischemic zones (necrotic tips) [8].
Pigs (and other mammals) have developed strategies
that inhibit maternal immune responses to fetal alloanti-
gens from paternal origin [9]. Thanks to this tolerance
phenomenon, embryos and fetuses are not rejected.
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fective defense against pathogens without rejecting the
fetus. This is a complex task in the maternal-fetal inter-
face, as its abundant blood supply makes it a favorable
place for pathogens to prosper. A number of cell types
within the maternal-fetal interface interact to protect
concepti from rejection and suppress a germ infestation.
Trophoblast cells are specialized epithelial cells that
possess several important functions [10]. Trophoblast
cells play a key role in protecting the embryo/fetus from
aggressive substances and preventing maternal immune
rejection, ensuring appropriate bidirectional nutrient/
waste flow required for growth and maturation of the
embryo. Interestingly, the tolerance to fetal antigens oc-
curs in the presence of a large number of maternal
endometrial leukocytes [11]. Following placentation, dis-
tinct cellular changes in the local immune cell environ-
ment of the uterus are observed despite the non-invasive
nature of the pig placenta. This happens presumably in
response to trophoblast and/or fetal antigens. During
the first month of gestation, at sites of conceptus attach-
ment, the number of uterine lymphocytes decreases in
the uterine epithelium and increases in the endometrial
stroma. The majority of these lymphocytes express CD2
and CD8 surface markers, consistent with either T or
natural killer (NK) cell lineage [9]. The role of T-
lymphocyte subpopulations during the establishment of
the epitheliochorial porcine placenta is largely unclear [3].
According to Haverson et al. [12], subpopulations of
myeloid cells (neutrophils, eosinophils, monocytes and
macrophages) in swine peripheral blood and lymphoid
tissue express the SWC3 antigen. SWC3-expressing cells
(most probably macrophages) are also commonly found
in all layers of the endometrium of non-pregnant sows
[13]; however the function of these cells has not yet been
well studied. In the human decidua, macrophages ex-
press molecules that down-regulate inflammation and
promote tissue remodeling as well as tolerance to for-
eign fetal (paternal) antigens [14].
2. Pathology of gestation in the swine
In the present section, a short overview [15,16] of repro-
ductive pathology during porcine gestation is given.
Clinical manifestation of pathological processes de-
pends on the period of prenatal development during
which these processes occur. Death of embryos prior to
implantation generally results in resorption of embryos
and regular return to estrus in sows. Concepti are most
probably also resorbed when death occurs between 14
and 35 days of gestation prior to skeleton formation.
Sows will have an irregular return to estrus if all con-
cepti die during that period or will farrow a small litter
when only a proportion of the embryos die. Death of the
fetus can be followed by mummification when it occursafter the embryonic period. Mummies are fetuses that
died in utero and become exsiccated. Abortion results
from the termination of gestation, with subsequent ex-
pulsion of all concepti and is associated with maternal
and/or embryonic/fetal failure. Abortion takes place
from day 14 (although abortion generally takes place
during the fetal period starting from 25 days of gesta-
tion) to day 109 of gestation (fetuses expelled before day
109 of gestation normally cannot survive). Aborted sows
return to estrus within 5–10 days or experience a
prolonged anestrus. In abortion due to maternal failure,
fetuses are generally all of the same size. A combination
of mummies and dead piglets of variable size is observed
when fetuses die at different times of gestation. Early
farrowing occurs between 109 and 111 days of gestation
and is associated with a high proportion of dead and low
viable piglets. Stillbirth results from the expulsion of a
dead fetus at term. Stillborn pigs die either prepartum or
intrapartum and are grossly normal at birth.
3. PRRSV infection in pregnant sows
3.1. Introduction
In 1987, a new disease of unknown etiology character-
ized by reproductive failure in gilts and sows, and re-
spiratory problems in young pigs, was observed in the
USA and Canada [17,18]. Three years later, a similar
outbreak was reported in Germany [19], with subsequent
rapid spread through the major swine-producing areas
in Western Europe. For the first time, a novel RNA virus
was isolated from diseased animals and Koch’s postulates
were fulfilled in 1991, in The Netherlands [20,21]. The
etiological agent of PRRS was named Lelystad virus.
Shortly thereafter, the etiology of PRRS was further
confirmed by isolation of the virus and experimental
reproduction of the disease in the USA [22]. In 1992,
participants of the International Symposium on SIRS in
Minneapolis agreed to name the causative agent porcine
reproductive and respiratory syndrome virus (PRRSV).
In the following years the virus was found not only in
Western Europe and the USA, but also in Eastern
Europe and some Asian countries [23-25]. At present,
PRRS is the most economically important viral disease
in swine livestock worldwide with an estimated annual
cost of 560 million dollars in the USA [26]. In 2006, a
highly pathogenic PRRSV infected more than 2 000 000
pigs in China and posed a great concern to the global
swine industry [27].
3.2 Clinical signs
Clinical signs in pregnant gilts and sows during PRRSV
outbreaks are mostly characterized by red/blue disco-
loration of the ears and vulva, late-term abortion storms,
early farrowing and birth of mixed litters with living,
stillborn fetuses and fetuses in different stages of
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demic PRRSV infection vary from none to fever, leth-
argy, anorexia, pneumonia, regular and delayed return to
estrus, sporadic late-term abortions, early farrowing and
birth of mixed litters with living, stillborn fetuses and fe-
tuses in different stages of mummification [20,23,28]. A
fraction of animals within an affected livestock may es-
cape from initial infection and serve as a susceptible
target for subsequent waves of infection, supporting
prolonged endemics [30]. PRRSV infection and associ-
ated clinical signs have been reproduced in experimental
conditions. First experimental reproduction of congeni-
tal PRRSV infection in pregnant sows has been done by
Terpstra et al. [20]. Shortly afterwards, research groups
from all over Europe and the USA confirmed the etio-
logical role of PRRSV in reproductive disorders [31].
3.3 Routes of PRRSV transmission
PRRSV can be transmitted horizontally following con-
tacts between infected and naïve animals, as well as via
semen of infected boars [32,33]. The duration of virus
shedding in the semen of experimentally infected boars
varies largely from 2 to 92 days after infection [34]. The
virus can be shed with semen, even in the absence of
viremia and in the presence of neutralizing antibodies
[34]. This virus most likely reaches the tissues of the male
reproductive tract and semen by migration of infected
macrophages [35]. Once contaminated semen appears in
the uterus, infection presumably starts from the endomet-
rial tissues and regional lymph nodes following hemato-
genic or lymphogenic PRRSV dissemination throughout
the sow organism and viremia appears [35].
4. PRRSV infection in the conceptus
Most previous investigations are mainly focused on
transplacental PRRSV infection in pregnant sows and
explored virus replication in fetal internal organs. Upon
fetal infection, PRRSV replicates within fetal lymphoid
tissues [29,36]. The fetal thymus, tonsils, and lymph
nodes are the most regular sites for PRRSV replication
[29,36,37]. However, the virus is also detectible in fetal
lungs, liver, spleen, heart and kidneys [29,36-38]. The
virus recovery from fetal tissues shows transplacental in-
fection, but the absence of severe microscopic lesions in
the internal organs of aborted or stillborn fetuses leaves
the mechanism of reproductive failure unexplained
[29,39-41]. The latter assumes that fetal death might be
attributed to the virus-induced uterine/placental lesions.
In accordance with this, transmission electron micros-
copy revealed virus-like particles in the endometrium
and placenta collected from sows infected with PRRSV
[42]. In several studies myometritis, endometritis, pla-
centitis and microseparations in the maternal-fetal unit
were described in samples from experimentally andnaturally infected sows [31,39,42]. However, accurate
quantification of virus-positive cells, their fate and virus
colocalization with lesions in the endometrium and fetal
membranes were not performed up till recently. In re-
cent studies, new insight into the pathogenesis of PRRSV
infection in pregnant sows was obtained by studying the
virus replication and virus-induced pathology in the
endometrium and placenta [37,43-45]. The main conclu-
sion obtained from these studies is that PRRSV replica-
tion in the endometrium and placenta can contribute or
even be a prerequisite to fetal death and reproductive
disorders. The following subchapters highlight previous
studies on transplacental and embryo/fetal PRRSV infec-
tion and our own exploration of endometrial/placental
PRRSV infection.
4.1 Embryo PRRSV infection during early gestation
A reduction of swine reproductive performance, such as
low conception and fertilization rate, during field PRRSV
outbreaks might be attributed to PRRSV infection in the
early stage of gestation [46]. As a result, experimental
studies were performed to find out if exposure of gilts to
PRRSV in the onset and early gestation can influence
the conception rate and affect early embryos.
4.1.1 Embryo PRRSV infection during early gestation upon
intranasal sow inoculation
Inoculation of gilts at the day of insemination and sam-
pling after 10 days results in fewer embryos than can be
anticipated from the number of corpora lutea [47]. Later
euthanasia of inoculated gilts (20 days after exposure)
results in three times more dead embryos than in con-
trol non-inoculated gilts. Inoculation of gilts at 14 days
of gestation also leads to embryonic infection (collection
of embryos was performed at 20–22 days after maternal
exposure to PRRSV) [48]; however, the incidence of em-
bryonic infections is low, and the infected embryos do
not show pathology. The susceptibility of embryos to
PRRSV infection is also age-dependent. Ten-day-old em-
bryos are not susceptible to PRRSV upon intranasal in-
oculation of the mother. Twenty-day-old embryos may
contain infectious virus. It has been shown in vitro that
preimplantation embryos are resistant to PRRSV infec-
tion [49,50]. The most probable explanation for this ob-
servation is the absence of PRRSV receptor sialoadhesin
(Sn), on those embryos [50].
4.1.2 Embryo PRRSV infection during early gestation upon
in utero inoculation
Reports on outcomes of a sow insemination with
PRRSV-contaminated semen [51] and in utero exposure
of sows to the virus shortly after they had been bred nat-
urally [52] also exist, but the results are contradictory. In
the study of Prieto et al. [51], euthanasia of the in utero
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ence of dead and infected embryos. In contrast, in the
study of Lager et al. [52] an effect of PRRSV exposure
on the reproductive performance could not be demon-
strated. Inoculated gilts that were euthanized at term or
allowed to farrow showed no evidence of fetal infection,
and the number of live fetuses or newborn piglets did
not significantly differ from the control group. Remark-
ably however, in both studies PRRSV was transmitted
from the lumen of the uterus to the blood circulation
and internal organs of the dam [51,52].
Altogether, the described results suggest that PRRSV
infection has little or no effects on conception rates des-
pite the route of inoculation. However, it can result in
death and infection of embryos after implantation.
4.2 Fetal PRRSV infection during mid-gestation
Only sporadic cases of mid-gestation abortions or small
mummies at farrowing, indications of mid-term fetal in-
fection, have been reported during PRRS outbreaks [53].
Despite this, some investigations were aimed at studying
PRRSV infection in mid-gestation sows and fetuses upon
experimental inoculation.
4.2.1 Fetal PRRSV infection during mid-gestation upon
intranasal sow inoculation
Virus inoculation of sows between 40 and 50 days of
gestation does not cause pathology or PRRSV infection
in fetuses [38,53]. Only in the study of Christianson
et al. [53] the virus was isolated from few newborn pigs
of sows inoculated in mid-gestation.
4.2.2 Fetal PRRSV infection during mid-gestation upon
intrafetal/intra-amniotic inoculation
Mid-gestation sows are susceptible to infection when ex-
posed to the virus intranasally. However, transplacental
infection is not reproducible during this period of gesta-
tion. Intrafetal or intraamniotic inoculation with PRRSV
between 45 and 50 days of gestation results in produc-
tive infection in fetuses (sows were euthanized at
4–11 days after inoculation) [53], proving that the virus
does not readily cross from mother to fetus upon mater-
nal exposure in mid-gestation. In addition, the virus is
not able to pass from the fetus to the mother in that
period of gestation either [53].
As a conclusion, PRRSV replicates in mid-gestation
porcine fetuses upon direct inoculation, but does not
readily cross transplacentally from the mother to fetus
when sows are exposed intranasally and from fetus to
mother upon intrafetal/intra-amniotic inoculation.
4.3 Fetal PRRSV infection during late gestation
Clinical manifestation of PRRS in gilts and sows is
mostly described as late-term reproductive failure. Anumber of studies were aimed at providing the experi-
mental evidence of transplacental PRRSV infection and
reproductive failure in late-gestation.
4.3.1 Fetal PRRSV infection during late gestation upon
intranasal sow inoculation
Experimental inoculation of sows with various PRRSV
strains during late-gestation (72 to 93 days of gestation)
consistently results in transplacental infection and repro-
ductive failure that is similar to field observations
[20,29,31,38,54,55]. A higher incidence of congenital
infections and a higher number of infected fetuses/new-
born pigs are observed upon inoculation of sows at
85–92 days of gestation in comparison to sows inocu-
lated at 72 days of gestation [29,38]. In accordance with
this, more pronounced reproductive disturbances are
observed in sows inoculated later in gestation [38].
4.3.2 Fetal PRRSV infection during late gestation upon
intra-amniotic inoculation
Fetuses are susceptible to PRRSV infection upon intra-
amniotic inoculation during late gestation [56]. Fetal in-
oculation during late gestation may result in fetal death
within days after exposure.
4.4 Exploring endometrial/placental PRRSV infection
Recent studies indicate that the endometrium and pla-
centa are involved in the PRRSV passage from the
mother to fetus and that virus replication in the endo-
metrial/placental tissues during late gestation is the ac-
tual reason for fetal death [37,43-45,57]. The following
sections review the findings.
4.4.1 Why is PRRSV passage from mother to fetus restricted
to late gestation?
Despite the clear susceptibility of fetuses to PRRSV upon
direct intra-fetal inoculation at any stage of gestation,
exposure of sows and gilts to PRRSV only results in
congenital infection and reproductive failure in late ges-
tation in the field as well as under experimental condi-
tions. Altogether, these observations indicate that the
endometrium/placenta determines the passage of PRRSV
to the embryos/fetuses. It is already known that PRRSV
has a restricted tropism to Sn+CD163+ macrophages and
that preimplantation embryos that do not have Sn+ cells
cannot be infected [50,58]. Consequently, the presence
of PRRSV target cells in the endometrium and placenta
may be essential for virus passage from mother to fetus.
Therefore, Sn+ and CD163+ macrophages, the cells
potentially susceptible to PRRSV, were localized and
quantified in the endometrium/placenta and organs of
embryos/fetuses at different days of gestation (20–35,
50–60, 70–80, 114) [43]. A high number of CD163+ cells
was observed within the endometrium/placenta during
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ples collected at different stages of gestation also con-
stantly contained Sn+ cells. In contrast, variations were
observed in the placenta. At 50–60 days of gestation,
Sn+ cells were not detected in the placenta of eleven fe-
tuses out of fifteen tested. Almost all fetuses had Sn+
cells in the placenta at 70–80 days of gestation, and all
fetuses had Sn+ cells at 20–35 and 114 days of gestation.
The actual number of Sn+ cells in the placenta was con-
siderably lower at 20–35 days of gestation (range 1–20;
mean 7 cells/microscopic field) and even at 70–80 days
of gestation (range 0–20; mean 6 cells/microscopic field)
than at 114 days of gestation (range 3–48; mean 16
cells/microscopic field). In line with this, the high num-
ber of CD163+ and Sn+ cells was also observed in the
endometrium and placenta collected at 100 and 110 days
of gestation (data are not published). The abundance of
cells that are highly susceptible to the virus in the pla-
centa in late gestation may in part explain why congeni-
tal infection of PRRSV is mostly restricted to the end of
gestation.
A previous challenge experiment revealed that the
endometrial environment may also play an important
role in the establishment of placental and transplacental
PRRSV infections [37]. PRRSV-positive cells were not
observed in the endometrial tissues adjacent to eleven
fetuses of one sow that was intranasally inoculated with
PRRSV at 70 days of gestation and sampled at 80 days of
gestation, despite maternal viremia and the presence of
endometrial CD163+ and Sn+ cells. In contrast, PRRSV
efficiently replicated in the endometrium/placenta col-
lected from sows intranasally inoculated with PRRSV at
90 days of gestation and sampled at 100 days of gesta-
tion. Two possible obstructions may be present for
PRRSV to find its way from maternal blood to the endo-
metrium before 90 days of gestation. Most probably
PRRSV passage from maternal blood to endometrial
connective tissues happens in association with blood
monocytes migrating through endometrial vessels.
Endometrial blood vessels might restrain cell-associated
PRRSV passage from maternal blood to endometrial
connective tissues at 70–80 days of gestation. Alterna-
tively, yet unknown cellular/molecular endometrial fac-
tors may block PRRSV replication in local macrophages
(in addition, virus-infected macrophages may be rapidly
eliminated) at 70–80 days of gestation. A combination of
these scenarios is also possible. The comparative studies
of the endometrium from healthy and PRRSV-infected
sows at different terms of gestation may lead to an un-
derstanding of those factors, and as a consequence, may
help in designing new antiviral strategies to prevent pla-
cental and transplacental infections.
Altogether, the still unknown factors that prevent or
block PRRSV replication in the endometrium and thelack of susceptible cells in the placenta might join forces
and cause resistance to placental/transplacental PRRSV
infection before 90 days of gestation. Afterwards, the
endometrium and fetal membranes become more sus-
ceptible to PRRSV which most probably contributes
to the late term appearance of placental/transplacental
PRRSV infection and associated reproductive problems.
4.4.2 PRRSV replication in the endometrium and placenta in
late gestation
PRRSV-target cells are present in the endometrium/pla-
centa and PRRSV-infected macrophages in other organs
die by apoptosis. However, accurate quantification of
virus-positive cells, their fate and virus colocalization
with lesions in the endometrium and fetal membranes
were not performed until recently. In a recent study,
PRRSV-positive and apoptotic cells were identified,
localized and quantified in the endometrium/placenta
from three sows inoculated at 90 days of gestation and
euthanized 10 days later [37]. As a control, non-
inoculated sows were included in the study. At 10 days-
post inoculation, challenged sows were viremic and
PRRSV spread from mother to fetus was detected in all
of them. Severe histopathological lesions were not ob-
served in the endometrium/fetal placenta collected from
inoculated and control animals. In inoculated sows,
PRRSV replication was detected in the endometrium
and placenta via a specific immunofluorescence staining.
The number of PRRSV-positive cells in the placenta
(1-289/10 mm2 of tissue) was significantly higher than
in the endometrium (1-16/10 mm2 of tissue; p = 0.004).
The amount of apoptotic cells was significantly higher
in the PRRSV-positive endometrium from inoculated
sows versus virus-negative tissues from control sows.
The amount of apoptotic cells increased significantly in
the PRRSV-positive placentae compared to the PRRSV-
negative placentae. In the placenta a spatial correlation
between the sites of the PRRSV replication and apop-
totic cells was observed. The main conclusion obtained
from the study is that PRRSV replicates in the endomet-
rium/placenta and causes apoptosis of local cells in late
gestation.
4.4.3 PRRSV transmission from mother to fetus and from
fetus to fetus
Maternal viremia leading to PRRSV replication in the
endometrium with subsequent fetal infection through
the placenta is the most probable way of PRRSV trans-
mission from mother to fetus. The hypothetical model
of events during PRRSV infection in the endometrium/
placenta is given in Figure 2.
Similar to young pigs, upon intranasal inoculation of
sows, the primary sites for PRRSV replication are most
probably the respiratory tract and tonsils. Afterwards,
Figure 2 Events during PRRSV infection in the maternal-fetal interface in sows intranasally inoculated at 90 days of gestation.
1. Maternal blood vessel. 2. Endometrial connective tissue. 3. Uterine epithelium. 4. Trophoblast. 5. Fetal placental mesenchyme. 6. Fetal blood
vessel. (A) During viremia PRRSV attaches and probably enters and replicates in susceptible monocytes adhering to the endothelial cells of the
endometrial vessels. Extravasation of the PRRSV-bearing monocytes from maternal blood to the endometrium. (B) PRRSV replicates in the
endometrial macrophages. PRRSV causes apoptosis in infected and surrounding cells during replication within the endometrium. PRRSV crosses
the uterine epithelium and trophoblast, most probably in association with maternal macrophages. (C) Focal, highly efficient PRRSV replication in
the fetal placental macrophages. PRRSV reaches fetal internal organs most likely through the umbilical circulation. PRRSV causes apoptosis in
infected and surrounding cells during replication in the placenta. (D) Maternal immunity (most probably CD8+ endometrial NK cells) suppresses
PRRSV replication within the endometrium. Focal, highly efficient PRRSV replication in the placenta. (E) Focal detachment of the trophoblast from
the uterine epithelium and focal degeneration of the placenta, at the places of virus replication and probably in the adjacent sites. (F) Multifocal
degeneration and finally full degeneration of the placenta, at the places of virus replication, and probably in the adjacent sites.
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deliver PRRSV into the endometrial vessels. It has been
shown that in guinea pigs and rats, blood monocytes
pass through blood vessel walls via diapedesis into thetissues to further differentiate into macrophages (ex-
travasation). Diapedesis of monocytes can happen by mi-
gration straight through the microvascular monolayer of
endothelial cells (the transcellular route) or in between
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pedesis begins with the accumulation of leukocytes on
the luminal surface of the endothelium through a se-
quence of rolling, activation, and firm adhesion [60]. A
variety of monocyte and endothelium molecules and sig-
naling pathways are involved in trafficking [61,62]. Most
probably blood monocytes in pigs, like in guinea pigs
and rats, pass through endometrial vessel walls via dia-
pedesis into the endometrial connective tissues to fur-
ther differentiate into macrophages. Prior to or during
diapedesis (when blood monocytes differentiate) blood
monocytes may obtain the ability to attach PRRSV and
probably become infected. Upon invasion the virus
enters the endometrium with (on/in) differentiated
monocytes (Figure 2A). In support of this scenario,
PRRSV-positive cells are observed in between endothe-
lial cells of endometrial blood vessels [37].
The next step after PRRSV replication in the endomet-
rium towards placental infection is the virus crossing the
uterine epithelium and trophoblast layers. There are
three hypothetical modes of PRRSV crossing through
the uterine epithelium-trophoblast barrier:
– Direct cell to cell spread of PRRSV from infected
endometrial macrophages to the uterine epithelium
and subsequently through the trophoblast cells to
placental macrophages.
– Spread of free PRRSV particles directly through the
uterine epithelium and trophoblast cells or between
them.
– Cell-associated PRRSV spread from the
endometrium to concepti in/on macrophages
migrating from the mother to the fetus.
The direct spread of PRRSV from endometrial macro-
phages to the uterine epithelium and afterwards through
the trophoblast to fetal placental macrophages is less
probable than the two other ways of maternal-fetal virus
transmission. PRRSV has a very restricted tropism to
macrophages, and all PRRSV-infected cells within the
maternal-fetal interface are macrophages positive for
CD163 and Sn [37]. In contrast, the uterine epithelium
and trophoblast do not express these molecules and are
not susceptible to infection.
Pigs have an epitheliochorial placentation and even
antibodies are hindered in passing from the dam to the
fetus during porcine gestation. Taking into account that
IgG antibodies (12 nm) are significantly smaller than the
PRRSV virion (55 nm), the probability of the free PRRSV
particle spreading through the uterine epithelium/
trophoblast is very low. The ability of free virus particles
to pass might also depend on the integrity of the placen-
tal tissue layers. Mechanical rupture of one or several
tissue layers that separate maternal and fetal bloodcirculations may facilitate PRRSV transmission. In a few
cases, during the opening of uterine walls, we observed
hemorrhages under the alantochorion surface. However
the majority of the infected and negative fetuses did not
have any visible hemorrhages within the adjacent uterine
wall. It is not clear if the observed hemorrhages were
present prior to sow euthanasia or only appeared during
euthanasia and if they play any significant role in placen-
tal and transplacental PRRSV infection.
To the author’s opinion, cell-associated virus spread
from the endometrium to the fetal membranes, in/on
cells migrating from the mother to the fetus, is most
plausible (Figure 2B). The involvement of cell trafficking
from the mother to the fetus has been previously pro-
posed for congenital HIV [63] and LDV [64] infection.
In case of PRRSV infection, this hypothesis gains sup-
port from several lines of evidence. PRRSV has a very re-
stricted tropism to some subsets of macrophages and all
infected cells within the endometrium are CD163+ and
Sn+. Hypothetically, PRRSV-infected macrophages may
cross through the uterine epithelium and trophoblast
layers. The trafficking of different cell types across the
placenta is common in human and rodent pregnancies
[65]. Humans have hemochorial placentation which dis-
plays major differences from porcine epitheliochorial
placentation. Villi of the human placenta are covered by
the syncytiotrophoblast (an outer layer, maternal side)
and cytotrophoblast (an inner layer, fetal side). During
the first trimester of gestation the villi have a nearly
complete cytotrophoblast layer underneath the syncytio-
trophoblast layer. In later pregnancy, the internal
cytotrophoblast layer is discontinuous, and the syncytio-
trophoblast layer is the only barrier to be overcome by
maternal cells on their way to the fetal membranes. If
transplacental cell migration occurs during porcine ges-
tation and if it is responsible for PRRSV transmission
from the mother to fetus, two additional tissue layers be-
sides the trophoblast (syncytiotrophoblast in comparison
to humans) have to be crossed by migrating cells: the
endometrial connective tissues and the uterine epithe-
lium. PRRSV-target and virus-positive cells are abundant
within the endometrial connective tissues and these cells
are possibly free to move. It is yet unknown if local
endometrial cells can pass through the uterine epithe-
lium and porcine trophoblast. During screening of
uterine tissue sections stained with PRRSV-specific anti-
bodies, occasional virus-positive cells are observed in ex-
tremely close proximity to the uterine epithelium and
trophoblast (Figure 3). Those infected cells might be mi-
grating through the uterine epithelium and trophoblast.
Moreover, in our previous study, female cells were dem-
onstrated within the male fetuses. Those cells might
have a fetal, maternal or double origin [44]. The obser-
vations that the number of female microchimeric cells
Figure 3 PRRSV-positive macrophages in the endometrium (A) and placenta (B). PRRSV-positive macrophages (arrowed) in close proximity
to the uterine (maternal) epithelium (mep) and fetal trophoblast cells (tr). MSF: maternal secondary fold.
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number of male microchimeric cells within female fetal
tissues is in agreement with the scenario of a double ori-
gin (sibling and maternal) [44]. It can be proposed that
maternal macrophages are able to migrate from the
mother to fetus and serve as “Trojan horses” for PRRSV
invasion. However, the origin (maternal, sibling or
double) of female microchimeric cells within male fe-
tuses, the mechanism of their transmigration and their
ability to transfer infectious PRRSV remain to be experi-
mentally studied and proven.
After passing the uterine epithelium and trophoblast,
PRRSV-bearing cells reach the fetal placenta. Subse-
quently, a focal, very efficient PRRSV replication is ob-
served (Figure 2C). During PRRSV replication in the fetal
placental macrophages, virus-positive cells are localized
close to the fetal placental blood vessels [37]. Afterwards,
PRRSV-infected placental cells may reach fetal blood and
organs. In accordance with this, reverse migration of in-
flammatory monocytes from tissues back to the vascular
circulation has previously been described [66].
PRRSV replication is observed within the fetal liver,
thymus, spleen, lungs, inguinal and mesenteric LN in
late gestation [37,44,45]. This is in line with the findings
that susceptible CD163+Sn+ macrophages are abundant
within the fetal internal organs [43]. PRRSV is also
detected in amniotic fluids (11 virus-positive amniotic
fluids out of 34 tested, PRRSV titres 1.3-5.8 log10
TCID50/mL; PRRSV-positive cells were also detected in
amniotic membranes of several fetuses; sows were inoc-
ulated at 90 days of gestation and sampled 20 days later)
(unpublished data). During productive PRRSV replica-
tion within fetal membranes, viral passage from fetus to
fetus may accelerate PRRSV infection of the fetuses inutero. PRRSV can be carried on/in migrating macro-
phages and/or as free virus between siblings via adherent
extremities of fetal membranes or through blood anasto-
moses which may exist between allantochorions of
neighboring concepti [8,67]. The use of carrier cells is
indirectly supported by the existence of sibling
microchimerism. Male cells are observed within the liver
and lungs of female fetuses and vice versa [44]. The pro-
posed way of virus in utero dissemination can be utilized
by other porcine pathogens. For example, intrauterine
spread of porcine parvovirus between fetuses has been
demonstrated [68].
4.4.4 Cellular events in the maternal-fetal interface upon
PRRSV infection
After invasion into the endometrium, PRRSV replicates
within susceptible local macrophages. During the course
of infection, immunity slowly clears the virus within the
endometrium (Figure 2D) [45]. As a result, less efficient
PRRSV replication is observed in the endometrium of
sows euthanized at 20 days post-inoculation (range 0–4,
mean 0.2 cells/10 mm2) [50] than in the endometrium
of sows euthanized at 10 days post inoculation (range
0–16, mean 4 cells/10 mm2) [37]. The depletion of sus-
ceptible Sn+ and CD163+ cells was not observed in these
samples (data are not published). The exact nature of
this local antiviral immunity within the endometrium is
not clear. Interestingly, sows inoculated with PRRSV at
90 days of gestation and sampled 10 days later have a
higher number of Sn+ cells in the endometrium and pla-
centa due to de novo Sn expression on local CD163+
cells [57]. Along with the increased number of Sn+
macrophages an increased number of CD8+ cells, which
are mostly CD3- and previously described as uterine
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endometrium. It is possible that endometrial CD8+ cells
activated by Sn+ macrophages take part in suppression
of PRRSV replication [57]. Therefore, the absence or
small numbers of CD8+ cells in the fetal allantochorion
may be a reason for the very efficient PRRSV repli-
cation (in comparison to the endometrium) [57]. Mac-
rophages infected with PRRSV possess a reduced
susceptibility toward peripheral blood NK cytotoxicity
in vitro [72]. However, endometrial NK cells are
unique and distinct from those from the peripheral
blood due to the special immunological environment
in the maternal-fetal interface [73,74]. For example,
uterine NK cells can be induced to secrete soluble fac-
tors that can inhibit HIV infection in vitro [75]; in
contrast, human peripheral blood NK cells do not
exhibit such activity.
The excessive number and/or altered function of
endometrial/placental macrophages can theoretically dis-
rupt a delicate immunological balance in the maternal-
fetal interface and contribute to the previously described
placental lesions [45]. Upon PRRSV infection, differenti-
ated Sn-positive macrophages might activate endomet-
rial NK cells; afterwards, activated NK cells might
damage the semiallogeneic trophoblast [57]. The
capacity of porcine endometrial NK cells to kill semiallo-
geneic trophoblast cells is already known [76]. Consist-
ent with this notion, the number of CD8+ cells in close
proximity to the uterine epithelium is significantly higher
in PRRSV-positive samples versus PRRSV-negative
samples [57].
More comprehensive understanding of local defensive
mechanisms in the endometrium and placenta upon
PRRSV infections can help to design new anti-viral strat-
egies which may be able to block virus replication prior
to an establishment of placental/transplacental infection.
Moreover, this knowledge will extend a general insight
into anti-microbial immunity during gestation.
4.4.5 Pathological outcome of PRRSV infection in the
maternal-fetal interface
Taking into account the highly efficient PRRSV replica-
tion within the fetal placental mesenchyme and the
crucial role of the placenta for the normal development
of fetuses during gestation, it is plausible that
virus-induced placental damages are responsible for
PRRSV-related reproductive problems. At 20 days post-
inoculation (inoculation at 90 days of gestation), severe
histopathological lesions, which range from local separ-
ation between the uterine epithelium and trophoblast to
complete degradation of the fetal placental mesenchyme,
are observed (Figure 2E and F) [45]. These histopatho-
logical lesions are incompatible with fetal life, since the
integrity between the maternal and fetal counterpartswithin the maternal-fetal interface is crucial for in utero
gas (O2/CO2) exchange, feeding and clearing of toxic
metabolites of the progeny. On the one hand, these le-
sions can be initiated by PRRSV damage of susceptible
fetal placental macrophages and bystander cells. At
10 days post-inoculation, a significantly higher number
of apoptotic (and probably necrotic) cells is observed
within the fetal placental mesenchyme from the PRRSV-
inoculated sows compared to the non-inoculated control
sows [37]. This massive killing of cells may lead to de-
struction of the fetal placental mesenchyme, which sup-
ports the trophoblast layer. On the other hand, PRRSV
replication in endometrial/placental macrophages can
indirectly influence the expression of integrins and
extracellular matrix proteins (or other junction proteins)
on the trophoblast and/or uterine epithelium. These
proteins are important for successful implantation and
placentation in pigs [77-80]. As a result, separations be-
tween the uterine epithelium and trophoblast may ap-
pear. These separations have been previously detected
via electron microscopy [42] and were also observed in
our recent study [45]. Subsequently, deterioration of
placental functions and finally placental degradation lead
to fetal death and clinical representations of congenital
PRRSV infection. In a recent study, PRRSV-positive cells
were also localized in the myometrium [45]. PRRSV
infection may influence and derange the timely myo-
metrial quiescence and activation which are important
during gestation and parturition, respectively.
To cause late abortion or preterm birth, PRRSV prob-
ably induces severe lesions in the maternal-fetal interface
of most if not all fetuses. If the virus replicates in the
maternal-fetal interface adjacent to a limited number of
fetuses, gestation ends at term but the infection might
result in stillbirth and/or the birth of living PRRSV-
positive fetuses. Even in the case of fetal survival, the
placental damages induced during the fetal period most
probably have prolonged negative consequences. The
quality of the embryonic and fetal environment has last-
ing effects, influencing postnatal health and disease [5].
5. Prevention of PRRSV infection in pregnant
sows
Field reports suggest that following PRRSV-induced re-
productive failure, sows develop a protective immunity.
These observations are based on the fact that affected
sows have a normal litter following rebreeding despite
the apparent circulation of the virus within the herd
[81]. Experimental data also prove full protection of
swine to a homologous PRRSV challenge [54,82]. There-
fore, vaccination is considered as the principal method
to control and treat PRRSV infection [83,84].
Two types of PRRSV vaccines are available: modified
live virus vaccines (MLV vaccines also called attenuated
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called inactivated vaccines). Attenuated vaccines are
generated by in vitro cell culture passaging of virulent
virus until an attenuated phenotype appears. Inactivated
vaccines are generated by chemical or physical inactiva-
tion of virulent viruses. MLV and KV vaccines are devel-
oped both from European and North American PRRSV
strains, and are used on most continents, since a strict
geographical genotype barrier no longer exists. Commer-
cial, inactivated vaccines are authorized for use in breed-
ing pigs as they should provide protection without
deleterious effects on reproduction. However, inactivated
vaccines do not induce virus neutralizing antibodies and
cannot prevent PRRSV infections, even after challenge
with homologous strains [85-89]. In contrast, attenuated
vaccines are able to induce virus neutralizing antibodies
and prevent virus replication in target cells, viremia and
clinical symptoms [90,91]. Despite these positive effects
full protection is only achieved against homologous
strains. Moreover, outbreaks of the acute syndrome,
characterized by abortion and high mortality in pregnant
sows, have been described after vaccination with the
North American type MLV vaccines [91,92]. Live North
American vaccine virus has also been isolated after field
clinical cases of PRRS [93]. Live vaccine virus has an un-
wanted tendency to spread not only within the vacci-
nated herds but also to neighboring non-vaccinated
herds. During spreading among pigs, the vaccine virus
can revert genetically [94-96], which apparently leads to
the observed clinical problems [93]. Experimental inocu-
lation of sows with North American vaccine-derived
PRRSV in late gestation results in subsequent transpla-
cental infection in accordance with field observations
[97]. European-type vaccine PRRSV can also replicate in
gilts after intranasal exposure and even cross from the
mother to the fetus, however with a less detrimental ef-
fect on the reproductive performance [98].
In a recent study, a killed PRRSV vaccine, produced
using a new quality-controlled viral inactivation proced-
ure and applied with a suitable adjuvant, was tested [45].
The results showed that the new inactivated vaccine is
able to prime the VN antibody response and to slightly
reduce the duration of viremia in gilts. It also reduces
the number of PRRSV-positive fetuses, and improves
fetal survival, but is not able to prevent congenital infec-
tion. Positive effects were most probably achieved via
reduction of the virus transfer from the endometrium
(the primary site for PRRSV replication prior to concep-
tus infection) to the placenta, because the number of
PRRSV-positive cells in the placentae was significantly
higher in unvaccinated versus vaccinated gilts [45]. This
vaccine may be recommended for use in endemically
infected farms alone or in combination with other vac-
cines to reduce losses due to PRRSV infection inpregnant sows. The aim is to activate the VN antibody
response before 80 days of gestation, when sows become
susceptible to placental/transplacental infection. Vaccin-
ation of gilts with a live vaccine before insemination or
during the early stage of gestation with subsequent
boosting with the new inactivated vaccine may offer new
perspectives for the prevention of PRRSV-induced re-
productive disorders [99].
The requirements for laboratory testing of PRRSV vac-
cines, prior to field vaccine evaluation in pregnant sows
were also summarized [45]. This may be helpful in writ-
ing a monograph. Three specific requirements are cru-
cial for PRRSV vaccine testing in pregnant sows. First of
all, the challenge should be performed at the end of ges-
tation (90 days of gestation), the time when pregnant
sows are the most susceptible to congenital PRRSV in-
fection. Secondly, a combination of different techniques
must be used to detect PRRSV in the following maternal
and fetal tissues: maternal blood, endometrium, fetal pla-
centa, fetal blood, thymus and liver. Finally, examination
of fetuses for gross pathology and of the endometrium/
placenta for virus-induced microlesions is required for
the evaluation of the candidate vaccine efficacy.
Alternatively, other immunotherapeutic strategies aim-
ing at the complete block of virus replication within the
endometrium, preventing PRRSV to be transmitted from
the endometrium to concepti, should be considered.
Blocking virus replication within the endometrium may
be achieved by the manipulation of the local immune
cells responsible for PRRSV elimination. Targeted
delivery of immunotherapeutic agents via target cell
receptor-specific immunoconjugates prior to infection
may be a useful strategy. The candidate cells for such
targeting in the endometrium might be CD8+ cells (pre-
sumably uterine NK cells, described above). Better
insight into the immune determinants able to control
maternal viremia, virus replication within the endomet-
rium and virus transmission from the endometrium to
the placenta, will finally lead to an appropriate prevent-
ive strategy.
6. Conclusions
In conclusion, the recent data strongly indicate that
PRRSV replicates and causes pathology in the endomet-
rium and placenta in late gestation. Virus replication in
the endometrium and placenta are responsible for the
range of PRRSV-related reproductive problems. More
comprehensive understanding of defensive immune me-
chanisms in the endometrium and placenta upon PRRSV
infection can help to design new immunotherapeutic
strategies that may be able to block virus transmission
from mother to conceptus. Moreover, this knowledge
will extend general insight into anti-microbial immunity
in the maternal-fetal interface.
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